Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

about

Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD

P2860

Q58701360-719C3576-F05B-4C30-B3E5-086E5EAC5080 Q58765669-E8D93F5F-D940-4EE3-8EB5-E2FF53516D65

P2860

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

Item

http://www.wikidata.org/entity/Q37670156

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

@en

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD.

@nl

type

Item

label

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

@en

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD.

@nl

prefLabel

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

@en

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD.

@nl

P1476

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

@en

P2093

Andrew S Greenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.

Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.

Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption

Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.

Human fatty liver disease: old questions and new insights

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.

P304

42-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB13-1500

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Douglas Mashek

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259395577

http://www.w3.org/2001/XMLSchema#string

P698

24357693

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

P932

3968431

http://www.w3.org/2001/XMLSchema#string

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

about

P2860

P2860

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932